TAZAWA, Y. and KONNO, T. Semiquantitative Assay of Serum Lipoprotein-X in Differential Diagnosis of Neonatal Hepatitis and Congenital Biliary Atresia. Tohoku J. exp. Med., 1980, 130 (3) , 209-217 -Sera from 83 infants with biliary atresia or neonatal hepatitis were examined for the presence of lipoprotein-X (Lp-X).
All the infants examined with biliary atresia were positive for Lp-X. Forty-three percent of infants with neonatal hepatitis were positive for Lp-X. The semiquantitative assay of serum Lp-X revealed that it was higher in the group of biliary atresia than in the group of neonatal hepatitis.
Out of 37 infants with biliary atresia 18 were positive for Lp-X in an eight-fold or greater dilution of serum.
On the other hand, only one of 46 infants with neonatal hepatitis was Lp-X positive in the same dilution.
The semiquantitative values of Lp-X were well correlated with quantitative levels of Lp-X, and the sera positive for Lp-X in eight-fold or greater dilutions had Lp-X levels of higher than 300 mg/100 ml. From these results the semiquantitative assay of serum Lp-X may be of value in helping to differentiate biliary atresia from neonatal hepatitis, especially in the early stage of the disease. serum lipoprotein-X; neonatal hepatitis; biliary atresia
We are often left with the difficult task of differentiating biliary atresia from neonatal hepatitis in the first month of life. Standard liver function tests have proved to be unreliable in differential diagnosis of cholestatic diseases in early infancy.
Liver biopsy and radioisotope excretion studies have been offered as more reliable diagnostic tools in these diseases.
Recently, lipoprotein-X (Lp-X) which is an abnormal lipoprotein appearing in the serum of obstructive jaundice has been shown to be a reliable parameter of cholestasis (Seidel et al. 1969 (Seidel et al. , 1973a . Since its detection methods are simple and easy, the Lp-X test would be useful as an initial diagnostic tool in obstructive jaundice in early infancy. Negative reaction to Lp-X has never been reported in infants with extrahepatic biliary atresia having no hepatic decompensation (Poley et al. 1973) , while in those with neonatal hepatitis syndrome, including paucity of the intrahepatic bile duct, Lp-X has been demonstrated to be undetectable, or much lower in concentration than in those with biliary atresia (Poley et al. 1973; Magani and Alaupovic 1976) . However, there is some controversy on the usefulness 210 Y. Tazawa and T. Konno of the Lp-X test in differential diagnosis of obstructive jaundice (Ross et al. 1970; Vergani et al. 1973) . In this study, we determined serum Lp-X levels in infants with neonatal hepatitis or biliary atresia, and found semiquantitative determina tion of serum Lp-X valuable in differential diagnosis of these diseases, especially in their early stages. PATIENTS Eighty-three patients were studied, of whom 37 (males 13, females 24) had extrahepatic biliary atresia and 46 (males 33, females 13) neonatal hepatitis.
Serum specimens from 47 infants with indirect hyperbilirubinemia were added to the-study as controls.
The mean age of the biliary atresia group was 55 days, ranging from 18 to 103 days, and that of the neonatal hepatitis group was 65 days, ranging from 24 to 98 days. The mean age of the indirect hyperbilirubinemia group was 32 days, ranging from 9 to 92 days. The final diagnosis of biliary atresia was made by operative cholangiography, and all patients with the illness underwent hepatic portojejunostomy.
Neonatal hepatitis was defined here as intrahepatic cholestasis caused by unknown etiology during early infancy, including paucity of the intrahepatic bile duct. Twenty patients who seemed to have a definite bile flow were diagnosed clinically without such diagnostic procedures as liver biopsy or cholangio graphy.
All such patients recovered completely during the follow-up period. The needle biopsy of the liver was performed on 26 patients with neonatal hepatitis. Histological findings revealed little or no evidence suggesting extrahepatic biliary atresia, such as prom inent proliferation of the bile duct, bile plugs in the interlobular bile ducts, or portal fibrosis. Operative cholangiography, however, was carried out in 6 of the biopsied patients because of persistent jaundice and acholic stools, in whom the extrahepatic bile duct was demonstrated to be patent.
The serum specimens for the Lp-X test were obtained from all patients after more than 4 hr of fasting. fold serial dilutions of serum were applied to the test, and the final dilution with positive reaction for immunoprecipitation or polyanion precipitation was expressed as a concentra tion of Lp-X. The quantitative determination of Lp-X was performed after the Magnani and Alaupovic (Magnani and Alaupovic 1972) .
METHODS

RESULTS
The results
of the Lp-X test and routine examinations of the patients examined are summarized in Tables 1 and 2 . Lp-X was demonstrated as being present in all serum specimens from the patients with biliary atresia, and 20 of 46 T.B., total bilirubin (mg/100 ml); D.B., direct bilirubin (mg/100 ml); GOT, glutamic oxalacetic transaminase (K.U.); GPT, glutamic pyruvic transaminase (K.U.); ALP, alkaline phosphatase (K-A.U.); T.C., total cholesterol (mg/100 ml); P.L., phospholipid (mg/100 ml). T.B., total bilirubin (mg/100 ml); D.B., direct bilirubin (mg/100 ml); GOT , glutamic oxalacetic transaminase (K.U.); GPT, glutamic pyruvic transaminase (K .U.); ALP, alkaline phosphatase (K-A.U.); T.C., total cholesterol (mg/100 ml); P .L., phospholipid (mg/100 ml).
(43%) infants with neonatal hepatitis were positive for Lp-X. On the other hand, all of 47 patients with indirect hyperbilirubinemia were negative for Lp-X (Table  3) . The incidence of Lp-X in relation to the diagnostic procedures of neonatal hepatitis is shown in Table 4 . Lp-X was positive in 45% of the patients with neonatal hepatitis clinically diagnosed and in 45% of those diagnosed on the basis of histological findings of biopsied liver specimens. However, 4 of 6 patients who were not differentiated from biliary atresia on the basis of clinical findings were negative for Lp-X, who underwent operative cholangiography, which demonstrated the extrahepatic bile duct to be patent.
The semiquantitative assay showed that serum concentration of Lp-X in the biliary atresia group was higher than that in the neonatal hepatitis group. Out of 37 with biliary atresia, 18 patients (48%) were positive for Lp-X in eight-fold or greater dilutions. In contrast, only one of 46 patients (2.1%) with neonatal hepatitis were positive for Lp-X in an eight-fold dilution. However, there was no relationship between the semiquantitative values of Lp-X and the age at which it was determined (Fig. 2) .
The quantitative analysis of Lp-X was made in 12 sera positive for Lp-X. The relationships between the semiquantitative and quantitative values are shown in Fig. 3 . The positive sera of Lp-X in eight-fold or greater dilutions were higher than 300 mg/100 ml.
There was no correlation between the status of serum Lp-X and other serum biochemical values including bilirubin, transaminase, alkaline phosphatase, total cholesterol, phospholipids and total bile acid ( Figs. 4, 5) . Total cholesterol and phospholipid levels were relatively higher in biliary atresia than in neonatal hepatitis. However, no significant difference was found between these biochemical parameters The relationships between the semiquantitative values of serum Lp-X and the levels of serum cholesterol or phospholipid in patients positive for Lp-X are shown in Fig. 6 . There was a significant relationship only between values of Lp-X and phospholipid levels of biliary atresia (p<0.01). 
DISCUSSION
The present study demonstrated that serum Lp-X was present in all infants with biliary atresia and in 43% of those with neonatal hepatitis. Semiquantitative values of serum Lp-X in biliary atresia was much higher than those in neonatal hepatitis. These results may suggest that semiquantitative assay of serum Lp-X is of value in helping to differentiate obstructive jaundice in early infancy; the presence of Lp-X in eight-fold or greater dilutions of serum indicates biliary atresia, and the absence of Lp-X at least excludes biliary atresia. Magnani and Alaupovic (1976) have reported that serum concentration of Lp-X is higher than 300 mg/100 ml in most infants with biliary atresia but rarely in those with neonatal hepatitis. This coincided with our semiquantitative study in the present series. About half of the infants with biliary atresia were positive for Lp-X in eightfold or greater dilutions of serum of which Lp-X levels were shown to be 300 mg/ 100 ml or higher by quantitative determination. On the other hand, only one of 46 infants with neonatal hepatitis was Lp-X positive in an eight-fold dilution of serum. Since semiquantitative values of serum Lp-X were shown to be correlated with quantitative ones, simplicity of semiquantitative determination may provide more suitability as a diagnostic screening test in obstructive jaundice in early infancy. Serial quantitative determinations of serum Lp-X at different times during the course of illness in combination with cholestyramine treatment have been indicated in order to differentiate neonatal hepatitis from biliary atresia (Campbell et al. 1974) . Lp-X levels may be reduced in neonatal hepatitis but unchanged or increased in biliary atresia during the course of cholestyramine treatment.
For such studies a semiquantitative Lp-X test may take the place of a quantitative one.
Although the mechanism of Lp-X formation has not been clearly understood, bile lipoprotein flowing into circulation has been shown to play an important role in formation of serum Lp-X. Lp-X appears as early as 11 hr after a ligation of the bile duct (Ritland and Bergan 1975) , and bile lipoprotein is transformed in vitro to Lp-X-like particles in a mixture with albumin or serum (Manzato et al. 1976 ). Such experimental evidence may indicate that regurgitation of bile into blood causes serum Lp-X formation after bile duct obstruction. Since complete obstruc tion of extrahepatic bile ducts is proved in infants with biliary atresia, it is no wonder that all the infants with the illness are Lp-X positive in high concentrations. However, in adults with extrahepatic biliary obstruction, the proportion of patients positive for Lp-X varies from 65% to 100% (Ross et al. 1970; Vergani et al. 1973; Seidel et al. 1973a ). Such differences may reflect incomplete obstruction, in various degrees, of the extrahepatic biliary tract in patients examined. Absence of Lp-X in infants with neonatal hepatitis may suggest patency of the biliary tree even though bile flow may be so impaired in the liver that intrahepatic cholestasis occurs.
The status of serum Lp-X in patients with neonatal hepatitis was not related to any results of routine liver function tests including direct serum bilirubin, cholesterol, phospholipid and bile acid levels. In the group of biliary atresia, serum levels of total cholesterol and phospholipids were increased and the levels of the latter were correlated to the Lp-X levels determined by a semiquan titative assay. The fact that the major components of Lp-X are unesterified cholesterol (22%) and phospholipids (66%) (Seidel et al. 1969 ) may provide a reason for correlation between Lp-X and phospholipid levels. However, in Lp-X positive infants with neonatal hepatitis, its level was not related to the values of serum cholesterol or phospholipids; these values were not different from those in Lp-X negative infants with the illness. This fact may suggest that not only bile regurgitation following biliary obstruction but also other factors are concerned with Lp-X formation in neonatal hepatitis. Lecithin-cholesterol acyl-transferase (LCAT), known to decrease in diffuse liver cell injury, may be a factor causing Lp-X formation (Wengeler et al. 1970) , as seen in familial LCAT deficiency in which serum Lp-X is detected in spite of the absence of liver cell damage or cholestasis (Gjone 1974 ). However, as unesterified cholesterol levels and LCAT activities were not estimated in this study, it is still not known whether or not LCAT might be concerned with Lp-X formation in neonatal hepatitis.
